Aurora Cannabis (ACB) vs Emergent BioSolutions (EBS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Aurora Cannabis (ACB) has outperformed Emergent BioSolutions (EBS) over the past year, losing 27.7% versus a loss of 28.7%. Over five years, EBS leads with a -86.1% price change compared with -93.7% for ACB. Emergent BioSolutions is the larger company by market cap ($362.5 million vs $282.4 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACB | EBS |
|---|---|---|
| Share price | $4.46 | $7.07 |
| Market cap | $282.36M | $362.50M |
| 1-day change | -2.83% | +1.73% |
| YTD return | +5.69% | -42.80% |
| 1-year return | -27.71% | -28.73% |
| 5-year return | -93.66% | -86.05% |
| Forward P/E | — | 6.76 |
| EPS (TTM) | $-0.59 | $-3.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.67 | $14.06 |
| 52-week low | $2.56 | $4.36 |
| Distance from 52-week high | -33.08% | -49.72% |
| Analyst consensus | buy | none |
| Avg. price target upside | — | +55.59% |
| Average volume | 1.36M | 1.16M |
| Shares outstanding | 63.31M | 51.27M |
| Employees | 1,028 | 900 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Aurora Cannabis
ACB stock →Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Healthcare · Drug Manufacturers - Specialty & Generic · 1,028 employees
About Emergent BioSolutions
EBS stock →Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments.
Healthcare · Drug Manufacturers - Specialty & Generic · 900 employees
ACB vs EBS FAQ
Which is bigger, Aurora Cannabis or Emergent BioSolutions?
Emergent BioSolutions (EBS) is larger, with a market capitalization of $362.50M compared with $282.36M for Aurora Cannabis (ACB).
Which stock has performed better over the past year, ACB or EBS?
ACB returned -27.71% over the past 12 months, compared with -28.73% for EBS (price return, excluding dividends). Past performance does not predict future results.
Are Aurora Cannabis and Emergent BioSolutions in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.